Electromed (NYSE:ELMD) Stock Rating Lowered by StockNews.com

Electromed (NYSE:ELMD) was downgraded by research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a research report issued to clients and investors on Thursday.

Separately, TheStreet raised Electromed from a “c+” rating to a “b-” rating in a research note on Wednesday, February 21st.

Electromed Stock Down 1.5 %

ELMD stock opened at $14.18 on Thursday. The business’s 50-day moving average price is $15.18 and its 200-day moving average price is $12.09. The stock has a market cap of $122.09 million, a P/E ratio of 31.51 and a beta of 0.43. Electromed has a twelve month low of $8.80 and a twelve month high of $17.85.

Electromed (NYSE:ELMD) last issued its earnings results on Tuesday, February 13th. The company reported $0.19 earnings per share (EPS) for the quarter. The company had revenue of $13.69 million for the quarter. Electromed had a return on equity of 10.32% and a net margin of 7.62%.

Hedge Funds Weigh In On Electromed

Large investors have recently bought and sold shares of the business. Cetera Advisor Networks LLC purchased a new position in Electromed during the 2nd quarter valued at $129,000. State Street Corp lifted its holdings in shares of Electromed by 23.3% in the 1st quarter. State Street Corp now owns 14,529 shares of the company’s stock worth $181,000 after buying an additional 2,742 shares during the period. Gabelli Funds LLC lifted its holdings in shares of Electromed by 17.3% in the 4th quarter. Gabelli Funds LLC now owns 20,367 shares of the company’s stock worth $222,000 after buying an additional 3,000 shares during the period. BlackRock Inc. lifted its holdings in shares of Electromed by 7.6% in the 2nd quarter. BlackRock Inc. now owns 20,521 shares of the company’s stock worth $220,000 after buying an additional 1,452 shares during the period. Finally, Northern Trust Corp lifted its holdings in shares of Electromed by 4.7% in the 2nd quarter. Northern Trust Corp now owns 29,078 shares of the company’s stock worth $311,000 after buying an additional 1,306 shares during the period. Hedge funds and other institutional investors own 40.82% of the company’s stock.

Electromed Company Profile

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function.